|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Scarpa A, Sikora K, Fassan M, et al:
Molecular typing of lung adenocarcinoma on cytological samples
using a multigene next generation sequencing panel. PLoS One.
8:e804782013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fan Z and Schraeder R: The changing
pathology of lung cancer. Surg Oncol Clin N Am. 20:637–653. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bremer RE, Scoggin TS, Somers EB,
OShannessy DJ and Tacha DE: Interobserver agreement and assay
reproducibility of folate receptor α expression in lung
adenocarcinoma: A prognostic marker and potential therapeutic
target. Arch Pathol Lab Med. 137:1747–1752. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sunaga N, Kaira K, Tomizawa Y, et al:
Clinicopathological and prognostic significance of interleukin-8
expression and its relationship to KRAS mutation in lung
adenocarcinoma. Br J Cancer. 110:2047–2053. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shim HS, Lee da H, Park EJ and Kim SH:
Histopathologic characteristics of lung adenocarcinomas with
epidermal growth factor receptor mutations in the International
Association for the Study of Lung Cancer/American Thoracic
Society/European Respiratory Society lung adenocarcinoma
classification. Arch Pathol Lab Med. 135:1329–1334. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shimada Y, Saji H, Nomura M, Matsubayashi
J, Yoshida K, Kakihana M, Kajiwara N, Ohira T and Ikeda N: Cancer
stem cell-related marker expression in lung adenocarcinoma and
relevance of histologic subtypes based on IASLC/ATS/ERS
classification. Onco Targets Ther. 6:1597–1604. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Travis WD, Brambilla E, Noguchi M,
Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ,
Van Schil PE, et al: International association for the study of
lung cancer/american thoracic society/european respiratory society
international multidisciplinary classification of lung
adenocarcinoma. J Thorac Oncol. 6:244–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maeda R, Yoshida J, Ishii G, Hishida T,
Nishimura M and Nagai K: Prognostic impact of histology on
early-stage non-small cell lung cancer. Chest. 140:135–145. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang J, Wu J, Tan Q, Zhu L and Gao W: Why
do pathological stage IA lung adenocarcinomas vary from prognosis?
A clinicopathologic study of 176 patients with pathological stage
IA lung adenocarcinoma based on the IASLC/ATS/ERS classification. J
Thorac Oncol. 8:1196–1202. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ha SY and Roh MS: The new 2011
international association for the study of lung cancer/american
thoracic society/european respiratory society classification of
lung adenocarcinoma in resected specimens: Clinicopathologic
relevance and emerging issues. Korean J Pathol. 47:316–325. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cagle PT and Chirieac LR: Advances in
treatment of lung cancer with targeted therapy. Arch Pathol Lab
Med. 136:504–509. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang JY, Cui SY, Chen YT, Song HZ, Huang
GC, Feng B, Sun M, De W, Wang R and Chen LB: MicroRNA-650 was a
prognostic factor in human lung adenocarcinoma and confers the
docetaxel chemoresistance of lung adenocarcinoma cells via
regulating Bcl-2/Bax expression. PLoS One. 8:e726152013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Toh Y and Nicolson GL: The role of the MTA
family and their encoded proteins in human cancers: Molecular
functions and clinical implications. Clin Exp Metastasis.
26:215–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Y, Chao Y, Fang Y, et al: MTA1 promotes
the invasion and migration of non-small cell lung cancer cells by
downregulating miR-125b. J Exp Clin Cancer Res. 32:332013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang H, Fan L, Wei J, et al: Akt mediates
metastasis-associated gene 1 (MTA1) regulating the expression of
E-cadherin and promoting the invasiveness of prostate cancer cells.
PLoS One. 7:e468882012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou H, Xu X, Xun Q, et al: microRNA-30c
negatively regulates endometrial cancer cells by targeting
metastasis-associated gene-1. Oncol Rep. 27:807–812.
2012.PubMed/NCBI
|
|
19
|
Song Q, Li Y, Zheng X, Fang Y, Chao Y, Yao
K and Zhu X: MTA1 contributes to actin cytoskeleton reorganization
and metastasis of nasopharyngeal carcinoma by modulating Rho
GTPases and Hedgehog signaling. Int J Biochem Cell Biol.
45:1439–1446. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li SH, Tian H, Yue WM, Li L, Li WJ, Chen
ZT, Hu WS, Zhu YC and Qi L: Overexpression of metastasis-associated
protein 1 is significantly correlated with tumor angiogenesis and
poor survival in patients with early-stage non-small cell lung
cancer. Ann Surg Oncol. 18:2048–2056. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li S, Tian H, Yue W, Li L, Gao C, Si L, Li
W, Hu W, Qi L and Lu M: Down-regulation of MTA1 protein leads to
the inhibition of migration, invasion and angiogenesis of
non-small-cell lung cancer cell line. Acta Biochim Biophys Sin
(Shanghai). 45:115–122. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rami-Porta R, Crowley JJ and Goldstraw P:
The revised TNM staging system for lung cancer. Ann Thorac
Cardiovasc Surg. 15:4–9. 2009.PubMed/NCBI
|
|
23
|
Deng X, Du L, Wang C, Yang Y, Li J, Liu H,
Zhang J, Wang L, Zhang X, Li W, et al: Close association of
metastasis-associated protein 1 overexpression with increased
angiogenesis and poor survival in patients with histologically
node-negative gastric cancer. World J Surg. 37:792–798. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vermeulen PB, Gasparini G, Fox SB,
Colpaert C, Marson LP, Gion M, Beliën JA, de Waal RM, Van Marck E,
Magnani E, et al: Second international consensus on the methodology
and criteria of evaluation of angiogenesis quantification in solid
human tumours. Eur J Cancer. 38:1564–1579. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu C, Gui Q, Chen W, Wu L, Sun W, Zhang N,
Xu Q, Wang J and Fu X: Small interference RNA targeting tissue
factor inhibits human lung adenocarcinoma growth in vitro
and in vivo. J Exp Clin Cancer Res. 30:632011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ma Q, Li P, Xu M, Yin J, Su Z, Li W and
Zhang J: Ku80 is highly expressed in lung adenocarcinoma and
promotes cisplatin resistance. J Exp Clin Cancer Res. 31:992012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kauffmann M, Krüger T and Aebert H:
Surgery on extracorporeal circulation in early and advanced
non-small cell lung cancer. Thorac Cardiovasc Surg. 61:103–108.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang J, Song H, Liu B, Yu B, Wang R and
Chen L: Expression of Notch-1 and its clinical significance in
different histological subtypes of human lung adenocarcinoma. J Exp
Clin Cancer Res. 32:842013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yoshizawa A, Motoi N, Riely GJ, Sima CS,
Gerald WL, Kris MG, Park BJ, Rusch VW and Travis WD: Impact of
proposed IASLC/ATS/ERS classification of lung adenocarcinoma:
Prognostic subgroups and implications for further revision of
staging based on analysis of 514 stage I cases. Mod Pathol.
24:653–664. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang Y, Ng HH, Erdjument-Bromage H,
Tempst P, Bird A and Reinberg D: Analysis of the NuRD subunits
reveals a histone deacetylase core complex and a connection with
DNA methylation. Genes Dev. 13:1924–1935. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Manavathi B, Peng S, Rayala SK, Talukder
AH, Wang MH, Wang RA, Balasenthil S, Agarwal N, Frishman LJ and
Kumar R: Repression of Six3 by a corepressor regulates rhodopsin
expression. Proc Natl Acad Sci USA. 104:13128–13133. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jang KS, Paik SS, Chung H, Oh YH and Kong
G: MTA1 overexpression correlates significantly with tumor grade
and angiogenesis in human breast cancers. Cancer Sci. 97:374–379.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kai L, Wang J, Ivanovic M, Chung YT,
Laskin WB, Schulze-Hoepfner F, Mirochnik Y, Satcher RL Jr and
Levenson AS: Targeting prostate cancer angiogenesis through
metastasis-associated protein 1 (MTA1). Prostate. 71:268–280. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Minhajat R, Mori D, Yamasaki F, Sugita Y,
Satoh T and Tokunaga O: Organ-specific endoglin (CD105) expression
in the angiogenesis of human cancers. Pathol Int. 56:717–723. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Paschoal JP, Bernardo V, Canedo NH,
Ribeiro OD, Caroli-Bottino A and Pannain VL: Microvascular density
of regenerative nodule to small hepatocellular carcinoma by
automated analysis using CD105 and CD34 immunoexpression. BMC
Cancer. 14:722014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tanaka F, Otake Y, Yanagihara K, Kawano Y,
Miyahara R, Li M, Yamada T, Hanaoka N, Inui K and Wada H:
Evaluation of angiogenesis in non-small cell lung cancer:
Comparison between anti-CD34 antibody and anti-CD105 antibody. Clin
Cancer Res. 7:3410–3415. 2001.PubMed/NCBI
|
|
38
|
Wikström P, Lissbrant IF, Stattin P,
Egevad L and Bergh A: Endoglin (CD105) is expressed on immature
blood vessels and is a marker for survival in prostate cancer.
Prostate. 51:268–275. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang W, Zhang Y, Fu Z, Sun X, Mu D and Yu
J: Imaging proliferation of 18F-FLT PET/CT correlated
with the expression of microvessel density of tumour tissue in
non-small-cell lung cancer. Eur J Nucl Med Mol Imaging.
39:1289–1296. 2012. View Article : Google Scholar : PubMed/NCBI
|
